	Residential Fast-Food Exposures, Colorectal Cancer-Specific, and All-Cause Mortality: A Retrospective Study of CRC Cases from the Kentucky Cancer Registry. Nutr Cancer Adhikari J, Kavalukas S, Taylor KC, Guinn B, Zhang CH, DuPre N. PMID: 42295112 [PubMed - as supplied by publisher]
	The expression and clinical significance of miR-635 and miR-519d in gastric cancer patients. Front Genet Liu J, Gu Q, Chen C, Liu X. PMID: 42294502 [PubMed]
	Predictive value of NRI, NLR, PLR and LMR for therapeutic efficacy and prognosis in advanced rectal cancer patients treated with PD-1/PD-L1 immunotherapy. Front Surg Gao M, Gao Z, Wang Y, Song W. PMID: 42294444 [PubMed]
	Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy. Adv Radiat Oncol Shinghal A, Sanyal S, Pradhan S, Kapoor AR, Saini V, Bhaumik S, Datta A, Singla T, Giridhar P, Pujari L. PMID: 42294408 [PubMed]
	The role of NAD(+) metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities. Front Oncol Ma Z, Gong X, Liu F. PMID: 42294340 [PubMed]
	Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions. Front Oncol Abdelrahim M, Esmail A, Al-Judaibi B, Khorshid O, Sherrie B, Mazzaferro V. PMID: 42294332 [PubMed]
	Management of toxicities from antibody - drug conjugates in breast cancer. Front Oncol Gogia A. PMID: 42294323 [PubMed]
	Study of ÃŸ-catenin signaling pathway modulated by PTHrP in cell and animal colorectal cancer models. Front Oncol Birkenstok C, Carriere P, Novoa Díaz MB, Martín MJ, Gentili C. PMID: 42294316 [PubMed]
	TME remodeling and clinical challenges of immune checkpoint blockade in nasopharyngeal carcinoma. Front Oncol Ou C, Qi L, Lai H, Ye J, Tian X, Li Z. PMID: 42294284 [PubMed]
	Efficacy and safety of traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms: a meta-analysis of randomized controlled trials. Front Oncol Zhao ZG, Xu WG, Zhang R, Li XM, Yang C, Wang L, Xie J. PMID: 42294274 [PubMed]
	Utilizing intraoperative frozen section examination (IFSE) for diagnosis and treatment in a high-clinical-suspicion prostate cancer (PCa) cohort based on (18)F-PSMA PET/CT and MRI: a pilot study. Transl Androl Urol Zhu LY, Fang M, Luan Y, Huang TB, Lu SM, Xiao Q, Chen J, Tan X, Ding XF. PMID: 42293831 [PubMed]
	Magnetic Resonance Imaging Features as Predictors of Response and Prognosis Following Neoadjuvant Therapy in Rectal Cancer: A Retrospective Cohort Study. Clin Med Insights Oncol Deng J, Cheng S, Li S, Hou Y. PMID: 42293813 [PubMed]
	Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma. JTO Clin Res Rep Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK. PMID: 42293288 [PubMed]
	Gut microbiome components predict response to neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): a prospective study. Front Pharmacol You Q, Jin M, Zhou B, Huang C, Lin Z, Hu J, Xue J, Chen X, Xiao Y, Li R, Zong Y, Wu M, Zhang T, Liu H. PMID: 42292847 [PubMed]
	Efficacy and safety of TiaoPi AnChang decoction to reduce CAPOX-Induced adverse reactions in Chinese patients with colorectal cancer: a randomized, double-blind, placebo-controlled trial. Front Pharmacol Zhang J, Guo Y, Hua Z, Liu M, Fu T, Ning W, Zhou L, Tang T, Song X, Wang C, Chen S, Zhang D, Liu H, Zhang G, Jie J, Cheng Z. PMID: 42292820 [PubMed]
	Determining the Correlation and Effect of Rectal and Bladder Volume Change in Shift of Planning Target Volume and Calculating Planning Target Volume Margin with Van Herk Formula in Prostate Cancer Tomotherapy. J Biomed Phys Eng Shabaninejad V, Shanei A, Roayaei M, Akhavan A, Saeb M, Hadinezhad S. PMID: 42292680 [PubMed]
	The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action. Front Immunol Li Y, Zhang J, Wu S, Liu Z, Qin S. PMID: 42292452 [PubMed - indexed for MEDLINE]
	Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation. Front Immunol Zeng X, Yang P, Wang T, Shi R, Qin C, Zhang L, Jiang T, Chen X, Luo H, Wei J, Hu H, Wang D, Wang J. PMID: 42292428 [PubMed - indexed for MEDLINE]
	The microbiota-metabolite-immune axis in colorectal cancer: mechanistic insights and emerging clinical applications. Front Immunol Sun B, Wang T. PMID: 42292406 [PubMed - indexed for MEDLINE]
	MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer. Front Immunol Zhang J, Tian F, Shang Y, Dai H, Zhang S, Kang B, Xin J, Wang X, Jing C, Sun C. PMID: 42292396 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 240973

Page 1 of 12049



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy